Ketamine for Depression and Anxiety
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this open-label study is to evaluate the effects of a single intravenous infusion of ketamine on depression and anxiety in adults with low vision.
Who Is on the Research Team?
Carolyn I Rodriguez, MD, PhD
Principal Investigator
Stanford University
Are You a Good Fit for This Trial?
This trial is for adults with low vision who are experiencing depression or anxiety. Participants must be able to safely receive ketamine and not have any medical conditions that would make the treatment unsafe.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Ketamine
Trial Overview
The study is testing a single intravenous dose of ketamine to see how it affects symptoms of depression and anxiety in adults with low vision. All participants will know they are receiving ketamine (open-label design).
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Adults with low vision, as determined by ophthalmology assessments
Healthy adults with normal vision and no psychiatric diagnosis
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.